With staffing shortages, historic burnout, and rising costs, concierge medicine — and direct primary care (DPC) — have moved from the margins into the middle of the retention conversation. The post From Executive Perk to Employee Retention Strategy: Why Concierge Medicine and/or Direct Primary Care Is Now a Business Essential appeared first on MedCity News.
With the election behind us, it’s time to lift healthcare above campaign rhetoric and invest in a care economy that breaks the cycle of chronic illness to build longer, healthier lives for all Americans. The post The People Behind America’s Health appeared first on MedCity News.
For every life lost, the ripple effects continue outward, often creating distinct suicide clusters, which account for as many as 5% of all suicides. Breaking this cycle is essential to preventing thousands of tragedies each year. The post Suicide Is Contagious appeared first on MedCity News.
Randomized controlled trials are the gold standard for evaluating treatment efficacy, but effectiveness in the real-world may vary. One reason for this is that clinical trials often have stricter inclusion criteria than is the case for the target treated population. Policymakers, payers, and clinicians may wonder how well the results from the narrower clinical trial…
This fact sheet examines the U.S. government’s role in addressing neglected tropical diseases (NTDs) worldwide.
SAN FRANCISCO, California — Organizaciones de salud sin fines de lucro e intérpretes médicos advierten que los recortes federales han eliminado docenas de puestos de trabajadores comunitarios en California, que ayudan a quienes no hablan inglés a obtener cobertura médica y a navegar el sistema de salud. Al mismo tiempo, las personas con dominio limitado…
[Sponsored] For many people, migraines interfere with daily life, work and relationships. Understanding what’s behind them — and how to manage them naturally — can be a powerful step toward lasting relief. The post The Best Way to Manage Migraines Without Medication appeared first on MedCity News.
From the FTC’s press release out today: Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’…
Arrowhead Pharmaceuticals’ RNAi drug plozasiran, brand name Redemplo, is now the second FDA-approved therapy for familial chylomicronemia syndrome, an inherited lipid disorder. Beyond its claims of safety and dosing advantages, Arrowhead set a dramatically lower price for its first commercial product, which will compete against an Ionis Pharmaceuticals drug. The post With FDA Approval for…
Deploying AI-driven segmentation at an enterprise level goes beyond operational efficiency. It signals a commitment to pioneering the next era of precision healthcare. The post Reimbursing Your Digital Twin: A New Era In Patient-Specific Surgery appeared first on MedCity News.